A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat; Daniel Stadlbauer; Shirin Strohmeier; Thi H O Nguyen; Veronika Chromikova; Meagan McMahon; Kaijun Jiang; Guha Asthagiri Arunkumar; Denise Jurczyszak; Jose Polanco; Maria Bermudez-Gonzalez; Giulio Kleiner; Teresa Aydillo; Lisa Miorin; Daniel S Fierer; Luz Amarilis Lugo; Erna Milunka Kojic; Jonathan Stoever; Sean T H Liu; Charlotte Cunningham-Rundles; Philip L Felgner; Thomas Moran; Adolfo García-Sastre; Daniel Caplivski; Allen C Cheng; Katherine Kedzierska; Olli Vapalahti; Jussi M Hepojoki; Viviana Simon; Florian Krammer

doi:10.1038/s41591-020-0913-5

A serological assay to detect SARS-CoV-2 seroconversion in humans

Nat Med. 2020 Jul;26(7):1033-1036. doi: 10.1038/s41591-020-0913-5. Epub 2020 May 12.

Authors

Fatima Amanat^{1

2}, Daniel Stadlbauer¹, Shirin Strohmeier^{1

3}, Thi H O Nguyen⁴, Veronika Chromikova¹, Meagan McMahon¹, Kaijun Jiang¹, Guha Asthagiri Arunkumar^{1

2}, Denise Jurczyszak^{1

2}, Jose Polanco^{1

5}, Maria Bermudez-Gonzalez¹, Giulio Kleiner¹, Teresa Aydillo^{1

6}, Lisa Miorin^{1

6}, Daniel S Fierer⁷, Luz Amarilis Lugo⁷, Erna Milunka Kojic⁷, Jonathan Stoever⁸, Sean T H Liu^{1

7

9

10}, Charlotte Cunningham-Rundles^{11

12}, Philip L Felgner¹³, Thomas Moran¹, Adolfo García-Sastre^{1

6

7

14}, Daniel Caplivski¹⁵, Allen C Cheng¹⁶, Katherine Kedzierska⁴, Olli Vapalahti^{17

18

19}, Jussi M Hepojoki^{17

20}, Viviana Simon^{1

6

7}, Florian Krammer²¹

Affiliations

¹ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
² Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
³ Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.
⁴ Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
⁵ Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁶ Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁷ Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁸ Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁹ Department of Medicine, Mount Sinai Queens, Astoria, NY, USA.
¹⁰ Division of Hospital Medicine, Mount Sinai Health System, New York, NY, USA.
¹¹ Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
¹² Department of Pediatrics, the Icahn School of Medicine at Mount Sinai, NY, USA.
¹³ Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA, USA.
¹⁴ Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
¹⁵ Travel Medicine Program, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
¹⁶ School of Public Health and Preventive Medicine, Monash University and Infection Prevention and Healthcare Epidemiology Unit Alfred Health, Melbourne, Victoria, Australia.
¹⁷ Department of Virology, Medicum, University of Helsinki, Helsinki, Finland.
¹⁸ Veterinary Biosciences, Veterinary Faculty, University of Helsinki, Helsinki, Finland.
¹⁹ Department of Virology and Immunology, Helsinki University Hospital (HUSLAB), Helsinki, Finland.
²⁰ Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland.
²¹ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. florian.krammer@mssm.edu.

Abstract

Here, we describe a serological enzyme-linked immunosorbent assay for the screening and identification of human SARS-CoV-2 seroconverters. This assay does not require the handling of infectious virus, can be adjusted to detect different antibody types in serum and plasma and is amenable to scaling. Serological assays are of critical importance to help define previous exposure to SARS-CoV-2 in populations, identify highly reactive human donors for convalescent plasma therapy and investigate correlates of protection.

Publication types

Observational Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Betacoronavirus / immunology*
Betacoronavirus / pathogenicity
COVID-19
COVID-19 Serotherapy
COVID-19 Testing
Case-Control Studies
Clinical Laboratory Techniques / methods*
Coronavirus Infections / blood
Coronavirus Infections / diagnosis*
Coronavirus Infections / immunology*
Coronavirus Infections / therapy
Coronavirus Infections / virology
Electrophoresis, Polyacrylamide Gel
Enzyme-Linked Immunosorbent Assay
Humans
Immunization, Passive
Longitudinal Studies
Middle Aged
Neutralization Tests
Pandemics
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / immunology*
Pneumonia, Viral / therapy
Pneumonia, Viral / virology
SARS-CoV-2
Seroconversion*
Young Adult

Abstract

Publication types

MeSH terms

Grants and funding